Skip to main content
. 2020 Sep 29;106(3):e1420–e1432. doi: 10.1210/clinem/dgaa692

Figure 2.

Figure 2.

(A) Remission rate of patients treated with MET, EX, or COM. (B) Percentage suppression of 2-hour glucose increment by each treatment. Two-hour glucose increments at baseline (before treatment) in each group were set to 100%. (C) The SIOGTT among patients treated with MET, EX, or COM. (D) Serum insulin levels at 2-hour post 75 g of oral glucose in patients treated with MET, EX, or COM.